Elyse Stock

Insider Reports History

Entity
Individual
Location
215 Church Street, New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elyse Stock:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Common Shares 0 $148.50 Oct 3, 2022 By Spouse
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Common Shares 0 $148.50 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Restricted Share Unit Award 0 Oct 3, 2022 By Spouse
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Stock Options (Right to Buy) 0 Oct 3, 2022 By Spouse
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Stock Options (Right to Buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by Elyse Stock

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 22 -$2.44M 4 Oct 3, 2022 Chief Medical Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 10, 2022 2 $0 4 Jan 12, 2022 Chief Medical Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 6, 2022 13 -$426K 4 Jan 7, 2022 Chief Medical Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Dec 14, 2021 11 -$2.63M 4 Dec 16, 2021 Chief Medical Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Nov 25, 2021 3 -$185K 4 Nov 26, 2021 Chief Medical Officer